VRA Reports Earnings Tomorrow: What to Expect
Vera Therapeutics reports Q2 2026 earnings June 11th. Analysts expect -$0.33 EPS on $50M revenue. Focus on atacicept IgA nephropathy program progress and cash runway.
Vera Therapeutics reports Q2 2026 earnings June 11th. Analysts expect -$0.33 EPS on $50M revenue. Focus on atacicept IgA nephropathy program progress and cash runway.
Coffee Holding Co. (JVA) reports quarterly earnings June 11, 2026. Investors focus on margin trends and supply chain management amid…
MH reports Q2 2026 earnings June 11 with analysts expecting $0.17 EPS on $450M revenue. Key focus on medical devices…
MSB reports quarterly earnings on June 10, 2026. Investors will focus on net interest margins, credit quality, and management guidance…
ME reports Q2 2026 earnings on June 10. Key focus areas include user growth, take rates, and profitability guidance amid…
RH reports Q1 2026 earnings June 10 with analysts expecting a $2.18 loss per share on $820M revenue as the…
Motorcar Parts of America Inc (MPAA) delivered a strong second quarter performance, reporting earnings per share of $0.42 versus analyst…
Mission Produce Inc (AVO) delivered mixed Q2 2026 results, reporting earnings per share of $0.01 versus analyst estimates of $0.06,…
VinFast Auto Ltd (VFS) reported extraordinary Q2 2026 results that defied all expectations, delivering revenue of $24.25 trillion against estimates…
Mama's Creations Inc (MAMA) delivered a strong earnings surprise for Q2 2026, reporting earnings per share of $0.05 versus analyst…